ERGÖREN, M. Ç. Et Al. 2021. Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience. EUROPEAN BIOTECHNOLOGY CONGRESS 2021 , (Sofija, Bulgaria), 49.

ERGÖREN, M. Ç., Paolacci, S., Manara, E., TUNCEL, G., Dhuli, K., Camilleri, G., ... SÜER, H. K.(2021). Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience . EUROPEAN BIOTECHNOLOGY CONGRESS 2021 (pp.49). Sofija, Bulgaria

ERGÖREN, MAHMUT Et Al. "Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience," EUROPEAN BIOTECHNOLOGY CONGRESS 2021, Sofija, Bulgaria, 2021

ERGÖREN, MAHMUT Ç. Et Al. "Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience." EUROPEAN BIOTECHNOLOGY CONGRESS 2021 , Sofija, Bulgaria, pp.49, 2021

ERGÖREN, M. Ç. Et Al. (2021) . "Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience." EUROPEAN BIOTECHNOLOGY CONGRESS 2021 , Sofija, Bulgaria, p.49.

@conferencepaper{conferencepaper, author={MAHMUT ÇERKEZ ERGÖREN Et Al. }, title={Clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection: North Cyprus ExperienceNorth Cyprus Experience}, congress name={EUROPEAN BIOTECHNOLOGY CONGRESS 2021}, city={Sofija}, country={Bulgaria}, year={2021}, pages={49} }